Grant: Discovery Grants Program - Individual
Université de Sherbrooke
$31,000.00
New mediators of osteoclast biology
FY 2017-18
Summary
Bone resorption and remodeling of the skeletal tissues in the higher vertebrates are required for development, mechanical adaptation, and mineral homeostasis. Osteoclasts (OCs) are bone-resorbing cells that maintain bone homeostasis. Published results: Alternative splicing (AS) plays a central role in protein diversity. To enhance our knowledge about OC biology, we have studied the expression of splice variants, hypothesizing that specific RNA splicing contributes to the OC phenotype. Using a PCR-based screening strategy, we searched for AS events in overactive and control OCs. This led to the identification of AS events in 6 genes, including LGALS8 (encoding galectin 8, GAL8) and TBC1D25, that were significantly associated with an overactive OC phenotype. Objectives: Our long-term objectives are to investigate splicing switches as a biological regulator of OCs activity, and to determine upstream signals that control any AS profile that would have been relevant. Our short-term objectives for the next 5 years are to identify the potential role of TBC1D25, a Rab-GTPase-activating protein (Rab-GAP), and GAL8, a -galactoside-binding lectin. We selected these two proteins because they are involved in vesicle trafficking in other systems and may interfere with OC polarization and because both impact bone resorption. The splice variants (elongation of the linker peptide in GAL8 or deletion of a large portion of TBC1D25 including the LC3 binding region and TBC domain) could alter the functions of the canonical forms. Scientific approach : A well-established RAW 264.7 murine cell line will be used to generate OCs in vitro. We will study the impact of each gene on the OC phenotype using siRNA and that of the predominantly expressed isoform using splicing isoform-specific inhibitors, including alternative exon-specific siRNAs, and a targeted oligonucleotide silencing of splicing. Aim #1: The expression of GAL8 and TBC1D25 isoforms will be evaluated by quantitative polymerase chain reaction (qPCR), western blotting, and immunofluorescence. Aim #2: Their functional impact on bone resorption, apoptosis, and autophagy will be evaluated. Aim #3: The interactions of GAL8 with p62 and NDP52 and those of TBC1D25 with Rab partners will be studied in immunoprecipitation studies. Feasibility : The techniques to be used have been successfully performed in our laboratory. The expression of GAL8 and TBC1D25 isoforms and their specific knockdown will be validated by qPCR, but commercial antibodies do not specifically differentiate between isoforms, and we may develop specific antibodies against TBC1D25 and GAL8 non-canonical isoforms. Novelty and significance : Evaluating AS as a catalyst of different biological functions of OCs, which could play a role in switching states between resorptive and non-resorptive OCs, is an original concept that may generate new insights into the regulation of OC biology.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2016-03900
Name nom
Roux, Sophie
Department département
Rhumatologie, Service de - Rhumatologie, Service de
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5102
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Inter-cellular communication
Research subject fr
Communication inter-cellulaire
Partie
2
Nb partie
5
Application title
New mediators of osteoclast biology
Keyword
NSERC
Application summary
Bone resorption and remodeling of the skeletal tissues in the higher vertebrates are required for development, mechanical adaptation, and mineral homeostasis. Osteoclasts (OCs) are bone-resorbing cells that maintain bone homeostasis. Published results: Alternative splicing (AS) plays a central role in protein diversity. To enhance our knowledge about OC biology, we have studied the expression of splice variants, hypothesizing that specific RNA splicing contributes to the OC phenotype. Using a PCR-based screening strategy, we searched for AS events in overactive and control OCs. This led to the identification of AS events in 6 genes, including LGALS8 (encoding galectin 8, GAL8) and TBC1D25, that were significantly associated with an overactive OC phenotype. Objectives: Our long-term objectives are to investigate splicing switches as a biological regulator of OCs activity, and to determine upstream signals that control any AS profile that would have been relevant. Our short-term objectives for the next 5 years are to identify the potential role of TBC1D25, a Rab-GTPase-activating protein (Rab-GAP), and GAL8, a -galactoside-binding lectin. We selected these two proteins because they are involved in vesicle trafficking in other systems and may interfere with OC polarization and because both impact bone resorption. The splice variants (elongation of the linker peptide in GAL8 or deletion of a large portion of TBC1D25 including the LC3 binding region and TBC domain) could alter the functions of the canonical forms. Scientific approach : A well-established RAW 264.7 murine cell line will be used to generate OCs in vitro. We will study the impact of each gene on the OC phenotype using siRNA and that of the predominantly expressed isoform using splicing isoform-specific inhibitors, including alternative exon-specific siRNAs, and a targeted oligonucleotide silencing of splicing. Aim #1: The expression of GAL8 and TBC1D25 isoforms will be evaluated by quantitative polymerase chain reaction (qPCR), western blotting, and immunofluorescence. Aim #2: Their functional impact on bone resorption, apoptosis, and autophagy will be evaluated. Aim #3: The interactions of GAL8 with p62 and NDP52 and those of TBC1D25 with Rab partners will be studied in immunoprecipitation studies. Feasibility : The techniques to be used have been successfully performed in our laboratory. The expression of GAL8 and TBC1D25 isoforms and their specific knockdown will be validated by qPCR, but commercial antibodies do not specifically differentiate between isoforms, and we may develop specific antibodies against TBC1D25 and GAL8 non-canonical isoforms. Novelty and significance : Evaluating AS as a catalyst of different biological functions of OCs, which could play a role in switching states between resorptive and non-resorptive OCs, is an original concept that may generate new insights into the regulation of OC biology.